Journal of Biological Chemistry · 2003 · 14 citations · 34 references
Life SciencesBiochemistryMolecular BiologyCell SignalingSignal TransductionStructural BiologyGrowth Factor SignalingLigand BindingReceptor BindingReceptor-ligand InteractionsAffinity EngineeringAffinity LigandsBiomolecular Binding AffinityChimera FormationDimerization SpecificityEpidermal Growth Factor Receptor SignalingGrowth Factor-receptor InteractionsReceptors
EGF-like growth factors activate their ErbB receptors by promoting receptor-mediated homodimerization or, alternatively, by the formation of heterodimers with the orphan ErbB-2 through an as yet unknown mechanism. To investigate the selectivity in dimer formation by ligands, we have applied the phage display approach to obtain ligands with modified C-terminal residues that discriminate between ErbB-2 and ErbB-3 as dimerization partners. We used the epidermal growth factor/transforming growth factor α chimera T1E as the template molecule because it binds to ErbB-3 homodimers with low affinity and to ErbB-2/ErbB-3 heterodimers with high affinity. Many phage variants were selected with enhanced binding affinity for ErbB-3 homodimers, indicating that C-terminal residues contribute to the interaction with ErbB-3. These variants were also potent ligands for ErbB-2/ErbB-3 heterodimers despite negative selection for such heterodimers. In contrast, phage variants positively selected for binding to ErbB-2/ErbB-3 heterodimers but negatively selected for binding to ErbB-3 homodimers can be considered as 舠second best舡 ErbB-3 binders, which require ErbB-2 heterodimerization for stable complex formation. Our findings imply that epidermal growth factor-like ligands bind ErbB-3 through a multi-domain interaction involving at least both linear endings of the ligand. Apparently the ErbB-3 affinity of a ligand determines whether it can form only ErbB-2/ErbB-3 complexes or also ErbB-3 homodimers. Because no separate binding domain for ErbB-2 could be identified, our data support a model in which ErbB heterodimerization occurs through a receptor-mediated mechanism and not through bivalent ligands. EGF-like growth factors activate their ErbB receptors by promoting receptor-mediated homodimerization or, alternatively, by the formation of heterodimers with the orphan ErbB-2 through an as yet unknown mechanism. To investigate the selectivity in dimer formation by ligands, we have applied the phage display approach to obtain ligands with modified C-terminal residues that discriminate between ErbB-2 and ErbB-3 as dimerization partners. We used the epidermal growth factor/transforming growth factor α chimera T1E as the template molecule because it binds to ErbB-3 homodimers with low affinity and to ErbB-2/ErbB-3 heterodimers with high affinity. Many phage variants were selected with enhanced binding affinity for ErbB-3 homodimers, indicating that C-terminal residues contribute to the interaction with ErbB-3. These variants were also potent ligands for ErbB-2/ErbB-3 heterodimers despite negative selection for such heterodimers. In contrast, phage variants positively selected for binding to ErbB-2/ErbB-3 heterodimers but negatively selected for binding to ErbB-3 homodimers can be considered as 舠second best舡 ErbB-3 binders, which require ErbB-2 heterodimerization for stable complex formation. Our findings imply that epidermal growth factor-like ligands bind ErbB-3 through a multi-domain interaction involving at least both linear endings of the ligand. Apparently the ErbB-3 affinity of a ligand determines whether it can form only ErbB-2/ErbB-3 complexes or also ErbB-3 homodimers. Because no separate binding domain for ErbB-2 could be identified, our data support a model in which ErbB heterodimerization occurs through a receptor-mediated mechanism and not through bivalent ligands. epidermal growth factor neuregulin transforming growth factor dimeric form of ErbB extracellular domains fused to the constant region of immunoglobulin G 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide enzyme-linked immunosorbent assay phosphate-buffered saline titrating units The recent determination of the crystal structure of the extracellular domain of ErbB-1 in complex with its ligands epidermal growth factor (EGF)1 or transforming growth factor α (TGF-α) has provided evidence for the formation of homodimeric ErbB-1 complexes through a receptor-mediated dimerization mechanism (1Garrett T.P. McKern N.M. Lou M. Elleman T.C. Adams T.E. Lovrecz G.O. Zhu H.J. Walker F. Frenkel M.J. Hoyne P.A. Jorissen R.N. Nice E.C. Burgess A.W. Ward C.W. Cell. 2002; 110: 763-773Google Scholar, 2Ogiso H. Ishitani R. Nureki O. Fukai S. Yamanaka M. Kim J.H. Saito K. Sakamoto A. Inoue M. Shirouzu M. Yokoyama S. Cell. 2002; 110: 775-787Google Scholar). Ligand binding to both domains I and III of the extracellular domain of the receptor involves the transition of ErbB-1 from a 舠closed舡 to an 舠open舡 state, which then permits dimerization with another liganded ErbB-1 through interaction of domain II residues within these receptors. Most likely this mechanism can serve as a paradigm for homodimerization of other liganded ErbB receptors, such as ErbB-3 and ErbB-4. However, it is well established that EGF-like growth factors preferentially signal through heterodimers of their cognate receptor with the orphan ErbB-2. The mechanism by which EGF-like growth factors bind their receptors in heterodimeric receptor complexes remains an open question. Dimerization of ligand-bound receptor tyrosine kinases is a mechanism that is thought to activate the intrinsic kinase domain followed by transphosphorylation and subsequent docking of cellular signal transducing proteins. As a consequence, ligand binding serves as a potential site for regulation of cell proliferation in diseases where ErbB receptors are overexpressed, as has been observed for ErbB-1 and ErbB-2 in multiple human cancers (3Yarden Y. Sliwkowski M.X. Nat. Rev. Mol. Cell Biol. 2001; 2: 127-137Google Scholar). ErbB-2 has no known ligand, but by decelerating the ligand dissociation rate, it serves as a preferred dimerization partner for all other ErbB members (4Riese II, D.J. Stern D.F. Bioessays. 1998; 20: 41-48Google Scholar, 5Karunagaran D. Tzahar E. Beerli R.R. Chen X. Graus-Porta D. Ratzkin B.J. Seger R. Hynes N.E. Yarden Y. EMBO J. 1996; 15: 254-264Google Scholar, 6Graus-Porta D. Beerli R.R. Daly J.M. Hynes N.E. EMBO J. 1997; 16: 1647-1655Google Scholar). Heterodimer formation with ErbB-2 is especially important in the case of the ErbB-3, which together with ErbB-4 forms the natural receptor for the different neuregulins (NRGs). ErbB-3 contains a defective kinase and, hence, ErbB-3 homodimers are biologically inactive (7Guy P.M. Platko J.V. Cantley L.C. Cerione R.A. Carraway III, K.L. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 8132-8136Google Scholar, 8Sliwkowski M.X. Schaefer G. Akita R.W. Lofgren J.A. Fitzpatrick V.D. Nuijens A. Fendly B.M. Cerione R.A. Vandlen R.L. Carraway III, K.L. J. Biol. Chem. 1994; 269: 14661-14665Google Scholar). The ErbB-2/ErbB-3 heterodimer, however, is the most prominent and strongest transforming signaling complex activated by NRG-1 (9Wallasch G. A. EMBO J. Scholar, M. A. R. Scholar, II, D.J. Stern D.F. Mol. Cell. Biol. 15: Scholar, R. H. G. S. Seger R. Ratzkin B.J. M. Yarden Y. EMBO J. 1996; 15: and an model to the mechanism of ErbB EGF-like growth factors a by and in to a linear and C-terminal and have that residues in the and C-terminal linear region of and bind to domain III of ErbB-1 followed by an interaction of residues in their with domain I of the receptor (1Garrett T.P. McKern N.M. Lou M. Elleman T.C. Adams T.E. Lovrecz G.O. Zhu H.J. Walker F. Frenkel M.J. Hoyne P.A. Jorissen R.N. Nice E.C. Burgess A.W. Ward C.W. Cell. 2002; 110: 763-773Google Scholar, 2Ogiso H. Ishitani R. Nureki O. Fukai S. Yamanaka M. Kim J.H. Saito K. Sakamoto A. Inoue M. Shirouzu M. Yokoyama S. Cell. 2002; 110: 775-787Google Scholar, L.C. Nice E.C. Burgess A.W. 1994; Scholar, Mol. Biol. 1994; Scholar, R.L. J.V. Proc. Natl. Acad. Sci. U. S. A. Scholar, J.V. J. Biol. Chem. 1996; Scholar). contrast, has been to bind with high affinity to a of ErbB-3 only domain I E. R. D. D. J. Biol. Chem. 2001; Scholar). binding to the of domain I of the that ligand binding to receptors involves interaction with domain I of the receptor J.H. Saito K. Yokoyama S. J. 2002; 269: Scholar). of that and residues in the linear region and the which form a site of the are the in ErbB-3 binding N.E. Sliwkowski M.X. D. 1996; Scholar, Lofgren J.A. Fitzpatrick V.D. J.A. Sliwkowski M.X. J. Biol. Chem. 1998; Scholar). the other residues in the C-terminal region of also a in receptor because the natural α and of NRG-1 and which only in C-terminal of the in their to bind and activate ErbB R. M. S. Ratzkin B.J. Yarden Y. J. Biol. Chem. 1996; Scholar, Cantley L.C. Carraway III, K.L. J. Biol. Chem. 1998; Scholar, A. M. Chen J.H. Proc. Natl. Acad. Sci. U. S. A. 1998; Scholar, Akita R.W. Sliwkowski M.X. Scholar). between and that the linear C-terminal region determines the binding and potential of these S. Ratzkin 1998; 15: Scholar). it has been that have a bivalent and with both ErbB-3 and ErbB-2 through separate binding E. R. G. M. S. M. Ratzkin B.J. M. Yarden Y. EMBO J. 1997; 16: Scholar). To the of residues in the linear C-terminal region of EGF-like ligands for dimer we applied the phage display to ligands that discriminate between ErbB-2 and ErbB-3 as dimerization in ErbB-3 In we and that in which the linear by or residues high binding affinity to ErbB-2/ErbB-3 only to ErbB-3 J. Biol. Chem. Scholar, M. 2002; Scholar). both T1E and subsequent binding of ErbB-2 to their low affinity interaction with ErbB-3. In a we could the ErbB-3 interaction of the chimera T1E in to the of in the linear a phage display approach we enhanced the binding affinity for ErbB-3 to T1E by of only residues in and E. 2002; Scholar). In the we have used the approach to residues in the linear C-terminal region of T1E for and selection for receptor selectivity and affinity. The residues in T1E to the in the that have been in the of ErbB we that T1E can be for binding to ErbB-3 by the phage display indicating that residues in the linear C-terminal contribute to the of ligands to bind ErbB-3 homodimers. despite negative selection we observed a between the of T1E variants to bind ErbB-3 and their to ErbB-2/ErbB-3 heterodimers. Because no for ErbB-2 heterodimerization could be identified, our findings support a model in which ErbB heterodimerization is by receptor-mediated and not by The of T1E has been M. 2002; Scholar). in the linear C-terminal region the in were by the residues of and by of The the were and the in from as The for the C-terminal region of the to as Lofgren J.A. Akita R.W. Sliwkowski M.X. J.A. J. Biol. Chem. 1998; and were in the and by and of T1E as M. 2002; Scholar). with human or were in with and selection or R. H. G. S. Seger R. Ratzkin B.J. M. Yarden Y. EMBO J. 1996; 15: Scholar). The human cell in a of modified and with were in modified with human and T1E were the to the for in a of of Ligand were as M. 2002; Scholar). phage of T1E by to at and by a approach as template E. 2002; Scholar, O. M. 1997; Scholar). The region in the growth factor followed by the the residues to Because the in of the a in the the site to the contains an between the phage Scholar). The the T1E were the phage both were and for phage The of by to the of the from the were by to the of and the were of were by both and determination and as units the extracellular domain of human ErbB receptors were fused to the and of the human to as X. G. Tzahar E. D. S. O. Ratzkin B.J. Yarden Y. J. Biol. Chem. 1996; were with the or a of with to the the dimeric were and by affinity a were with were by human as a the and of dimeric by and with human were at with of in of were in and for in of at were with of for in were and with in of binding for were by with were by the of of for and the with of The used for phage and of of were by of in with in of In the case of the were to as cell The from were to to with binding and to for a were in by for at followed by and a with were to to to the by with a of the and E. R. Yarden Y. M. 1997; at in binding for at a were and the as ErbB-2/ErbB-3 phage The were by a in of followed by of were for at and the as ErbB-3 The were used for phage and of of phage were used for the of in of of in with in were in of in phage of cell in were as E. 2002; Scholar). The for as Lofgren J.A. Fitzpatrick V.D. J.A. Sliwkowski M.X. J. Biol. Chem. 1998; with the homodimeric were at and heterodimeric were at in of binding that ErbB-2 and ErbB-3 were in to of were at a of in of with together with of or growth Cell of at the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide as E. 2002; Scholar). that the EGF-like ligands and T1E bind only to ErbB-3 to in the linear region E. R. G. M. S. M. Ratzkin B.J. M. Yarden Y. EMBO J. 1997; 16: Scholar, E. 2002; Scholar). The observed high affinity binding of T1E and for both ErbB-2 and ErbB-3 to of the complex by ErbB-2. The ErbB-2 as a dimerization partner this of a model for residues that the of ErbB-2 as a dimerization In this we have whether in the C-terminal linear region of T1E a in the formation of ErbB-3 homodimeric and ErbB-2/ErbB-3 heterodimeric as by a of the different we the C-terminal linear of of for the of and an has been from a phage display by selection for high affinity binding to ErbB-3 and contains the and with the domain Lofgren J.A. Akita R.W. Sliwkowski M.X. J.A. J. Biol. Chem. 1998; Scholar). The because it the with and because that of C-terminal residues binding affinity for ErbB-2/ErbB-3 heterodimers A. M. J. R. M. M. R.N. 1998; Scholar). The used for the T1E used in which is a chimera to the followed by to the and residues in the C-terminal T1E were as in E. by and for the by The of the T1E by binding stable of that ErbB R. H. G. S. Seger R. Ratzkin B.J. M. Yarden Y. EMBO J. 1996; 15: Scholar). in the of the T1E to T1E from ErbB-2 and ErbB-3 The of both and with T1E with enhanced affinity with were observed in the of these T1E to proliferation of and the human indicating that their binding affinity to the to activate ErbB-2/ErbB-3 complexes not in the C-terminal of T1E its to with ErbB-2/ErbB-3 heterodimers. the that is the natural for ErbB-2/ErbB-3 its C-terminal not for the interaction with ErbB-2/ErbB-3 in a T1E In this the residues in T1E in ErbB-2/ErbB-3 complexes the and To the of the linear in binding to ErbB-3, the binding affinity of the T1E ErbB-3 receptors In with we that is to homodimeric ErbB-3 complexes in R. H. G. S. Seger R. Ratzkin B.J. M. Yarden Y. EMBO J. 1996; 15: Scholar, E. R. G. M. S. M. Ratzkin B.J. M. Yarden Y. EMBO J. 1997; 16: Scholar). that all T1E have an affinity for ErbB-3 that is at least that of with binding and have binding affinity. of the C-terminal of T1E for not the binding of T1E to the ErbB-3 contrast, of the C-terminal of the the binding affinity of T1E for both heterodimeric ErbB-3 indicating these residues the of ErbB-2 and ErbB-3 of the of the these findings that residues in the C-terminal region of T1E contribute to the ligand for receptor To the of residues in T1E to the of ErbB-2 or ErbB-3 dimeric we in the linear of T1E that to the in the in ErbB binding a phage display a of and negative selection and we selected variants that between binding to ErbB-3 homodimers and to ErbB-2/ErbB-3 heterodimers. To this we used homodimeric in to human with of ErbB-2 and ErbB-3, which we have for affinity of variants to ErbB-2/ErbB-3 heterodimers E. 2002; Scholar). the of the phage of T1E The to is between and and the residues were for Because the is in to the with the a the phage to The display of the Scholar). The of the phage from the of the of different of an of the no from the T1E variants that preferentially bind to ErbB-3 homodimers but not ErbB-2/ErbB-3 heterodimers were selection homodimeric and the selection the phage were from the cell by with that are known to ligand binding E. R. Yarden Y. M. 1997; Scholar). the phage to ErbB-3 receptors the cell were by The between to and ErbB-3 receptors binding of and a selection by the dimeric with the receptors. phage were selection and for binding to ErbB-3 in phage I a of the of selected for binding to ErbB-3 homodimers with their binding of the to ErbB-2/ErbB-3 heterodimers in and heterodimeric Because these heterodimeric were by of the the receptors, were a of heterodimers and and homodimers. As a phage which is a with high affinity for ErbB-3 homodimers and ErbB-2/ErbB-3 heterodimers E. 2002; Scholar). T1E phage and phage were used as I that all ErbB-3 binding to with binding to both and despite the negative selection for ErbB-2 the T1E selected by this approach not their to bind to ErbB-2/ErbB-3 heterodimers. In other the ErbB-3 are to discriminate between ErbB-2 and ErbB-3 as dimerization and binding of ErbB-3 phage were for binding in phage and proteins. binding in to the phage to selection of or is a of selection of residues with an or phage were for binding in phage and proteins. binding in to the phage to selection of or is a of selection of residues with an or in a The most in the the selection of in of the ErbB-3 which is the in both and and to be in and at a for observed residues and were in of the ErbB-3 indicating that to be The most selected The for ErbB-3 the of of a at the in of all in which In an phage T1E variants were that to ErbB-2/ErbB-3 heterodimers but to bind to ErbB-3 homodimers. negative selection homodimeric the selection that ErbB-2 for high affinity binding were from the cell by with ErbB-2 cell the of T1E by this not of were and for binding in in a as for the ErbB-3 T1E selected for ErbB-2/ErbB-3 binding were to bind to both and that selection been the were for their to bind to ErbB-3 homodimers, of the binding for to phage T1E the were to bind with affinity to ErbB-3 homodimers only a of the to discriminate ErbB-3 as dimerization partner in the ErbB-3 and binding of ErbB-2/ErbB-3 phage were for binding in phage and binding in to the phage signal signal signal of selection of residues with a is a of selection of or selection of residues selection of residues which phage were for binding in phage and binding in to the phage signal signal signal of selection of residues with a is a of selection of or selection of residues selection of residues which in a the of the of both and The of could be as the of that of the ErbB-3 in The to bind to ErbB-3 homodimers of the with a of the from to residues were at and in all as observed for the ErbB-3 the of the the of with the for ErbB-3 To the of to the of ligands to bind ErbB-3, we a of selected phage variants to the and from the T1E that residues or or at both with residues were and as T1E as a for ErbB-2/ErbB-3 and phage as a for ErbB-3 phage used as a negative no binding could be by the used phage display the could be between the whether were as ErbB-3 or as were to bind with affinity to heterodimeric The binding of T1E to the low in to all other T1E variants and be to the region that is in the but in the T1E the binding affinity of the to between the and in the ErbB-3 were to the the ErbB-3 with C-terminal and affinity for ErbB-3 the indicating that C-terminal contribute to enhanced ErbB-3 affinity. the a or in ErbB-3 binding affinity observed in the T1E and residues to contribute to the ErbB-3 binding affinity at and to a at residues at both for ErbB-3 the of also to be Apparently the of the strongest ErbB-3 binding from the of ErbB-2/ErbB-3 has in the of the ErbB-3 binding In the of the T1E variants to activate ErbB-2/ErbB-3 heterodimers were by the proliferation of in an that all T1E variants are to phage and to phage T1E in in indicating that ErbB-2/ErbB-3 heterodimers are in to all the only bind to ErbB-3 homodimers, to but are of ErbB-2/ErbB-3 heterodimers. The ErbB-3 bind to ErbB-3 homodimers and ErbB-2/ErbB-3 to but this ErbB-3 affinity not in enhanced for ErbB-2 and ErbB-3. it that a low ErbB-3 binding is for the formation of ErbB-2/ErbB-3 heterodimers. EGF-like ligands in their to a dimerization partner for their cognate in and that ligands residues that interaction with ErbB heterodimers with the orphan ErbB-2. To investigate the selectivity in dimer formation by ligands, we have applied the phage display approach to obtain ligands with modified C-terminal residues that have selectivity and enhanced binding affinity. Our findings that EGF-like growth factors binding domains for ErbB-3, of which is in the C-terminal However, no separate binding domain for ErbB-2 could be in this ErbB-2/ErbB-3 heterodimerization to as a of a low affinity interaction with ErbB-3 and subsequent by ErbB-2. To the of dimer of and negative selection were applied to ligands that were to discriminate between ErbB-2 and ErbB-3 in complex formation with ErbB-3. of our the that the selectivity in of the dimerization partner is by in the linear C-terminal of ligands. of the ErbB-3 to form ErbB-2/ErbB-3 heterodimers despite the negative selection for T1E variants that ErbB-2 dimerization for The most likely is that the linear C-terminal region is not in the of ErbB-2 as dimerization partner because ligands not a separate ErbB-2 binding site or because such a site is in a different region of the ligand. our data not a model in which the linear C-terminal a binding site for as in ligand E. R. G. M. S. M. Ratzkin B.J. M. Yarden Y. EMBO J. 1997; 16: Scholar, M. D. J. EMBO J. 1997; 16: Scholar). the ErbB-3 formation observed for the that ligands require only a low of ErbB-3 binding affinity to the formation of ErbB-2/ErbB-3 heterodimers. These ligands can be considered as the 舠second best舡 ErbB-3 the that ligand variants positively selected for ErbB-3 binding but negatively for ErbB-2/ErbB-3 binding are potent of heterodimers also that binding to ErbB-3 is for formation. that the binding affinity to ErbB-3 is for the binding of ligands to dimeric such that low affinity only with ErbB-2/ErbB-3 high affinity can form ErbB-3 homodimers. Our for a separate ErbB-3 binding site in the linear C-terminal of EGF-like ligands. have and residues in the by the linear region and the region of NRG-1 as the for ErbB-3 binding N.E. Sliwkowski M.X. D. 1996; Scholar, Lofgren J.A. Fitzpatrick V.D. J.A. Sliwkowski M.X. J. Biol. Chem. 1998; Scholar, J. Biol. Chem. Scholar). however, be that residues in the ligand contribute to receptor residues in the in the of NRG-1 were also to this be to as well Lofgren J.A. Fitzpatrick V.D. J.A. Sliwkowski M.X. J. Biol. Chem. 1998; Scholar). The of residues by phage display the for or with or for ErbB-3 interaction E. 2002; Scholar, Lofgren J.A. Akita R.W. Sliwkowski M.X. J.A. J. Biol. Chem. 1998; Scholar). we that in the C-terminal linear region also contribute to the of T1E ligands to with ErbB-3 and that can for the of residues in the linear of the variants selected for binding to ErbB-3 homodimers binding to the residues in the and to to ErbB-3 residues in the linear C-terminal receptor in with the ErbB-3 binding of the NRG-1 that both linear of the ligand in receptor binding such that ligand binding to ErbB-3 occurs through a receptor The C-terminal for ErbB-3 binding can be from a of the of the selected high and low affinity ErbB-3 binding residues are preferred at and in all selected at In to enhanced ErbB-3 binding affinity. In the of an binding to ErbB-3, preferentially at ErbB-3 or, alternatively, at ErbB-3 Because a of the residues and also we that these are in in the structure of C-terminal residues with both domains I and III, which is (1Garrett T.P. McKern N.M. Lou M. Elleman T.C. Adams T.E. Lovrecz G.O. Zhu H.J. Walker F. Frenkel M.J. Hoyne P.A. Jorissen R.N. Nice E.C. Burgess A.W. Ward C.W. Cell. 2002; 110: 763-773Google Scholar). has been that these residues the of the ligand binding domains in the complex and the of the is to that in the T1E serve a binding to ErbB-3. all T1E variants selected for ErbB-3 binding their to bind to ErbB-1 and indicating that the in the C-terminal for ErbB-1 and ErbB-3 interaction S. S. M. and E. J. J. is the of selected a or at in T1E in which is ErbB-1 ligands and known to be to L.C. Nice E.C. Burgess A.W. 1994; Scholar, Mol. Biol. 1994; Scholar). the of the ErbB-3 with that of the natural ErbB-3 ligands, can that the linear C-terminal region positively to the interaction with ErbB-3. The that T1E forms ErbB-2/ErbB-3 heterodimers but not ErbB-3 homodimers can not be to C-terminal as it the of residues in both its and C-terminal region E. 2002; Scholar). The that of the T1E not the ErbB-3 binding affinity can be by the of only of and with a In of these residues to the ErbB-3 binding affinity of Lofgren J.A. Fitzpatrick V.D. J.A. Sliwkowski M.X. J. Biol. Chem. 1998; Scholar). natural ligands are not for high affinity to their receptors, which is also by the in ErbB-3 binding affinity of variants Lofgren J.A. Akita R.W. Sliwkowski M.X. J.A. J. Biol. Chem. 1998; Scholar). affinity to the to in the C-terminal as also by the in our despite the of residues in the T1E variants for ErbB-3 residues were not observed in which be to in the of T1E and Lofgren J.A. Akita R.W. Sliwkowski M.X. J.A. J. Biol. Chem. 1998; Scholar). We have the structure of G. and E. J. in but because that of the is a is Our imply that residues in the C-terminal of ligands are in interaction with ErbB-3 but not ErbB-2. it that the formation of heterodimeric ErbB complexes is through bivalent binding of ligands to different ErbB our findings support a receptor-mediated dimerization in which ligand binding to ErbB-3 determines the formation of both ErbB-3 homodimers and ErbB-2/ErbB-3 heterodimers In a of this it has been that ligands only ErbB-3 homodimers, which ErbB-2 a complex G. Cerione R.A. J. Biol. Chem. 1997; Scholar, X. J. 1998; Scholar, M.J. EMBO J. Scholar, J. Cell. Scholar). the of the crystal of ErbB-1 and ErbB-3, it is most likely that homodimeric ErbB-3 complexes are through a mechanism with a (1Garrett T.P. McKern N.M. Lou M. Elleman T.C. Adams T.E. Lovrecz G.O. Zhu H.J. Walker F. Frenkel M.J. Hoyne P.A. Jorissen R.N. Nice E.C. Burgess A.W. Ward C.W. Cell. 2002; 110: 763-773Google Scholar, 2Ogiso H. Ishitani R. Nureki O. Fukai S. Yamanaka M. Kim J.H. Saito K. Sakamoto A. Inoue M. Shirouzu M. Yokoyama S. Cell. 2002; 110: 775-787Google Scholar, D.J. 2002; Scholar). In this the ligand bind domain I of ErbB-3 through the linear and its C-terminal residues with receptor domain In the selectivity between the formation of inactive ErbB-3 homodimers and ErbB-2/ErbB-3 heterodimers be through the intrinsic of a ligand to bind ErbB-3 with high affinity for domain I III of ErbB-3, and of the ErbB-3 variants selected have a high to ErbB-3 the open dimerization and both ErbB-3 homodimers and ErbB-2/ErbB-3 heterodimers. with low affinity for ErbB-3 to interaction with domain I or III, such as T1E and have only a low to ErbB-3 the open state, and only in the case the liganded ErbB-3 is by ErbB-2 is a stable complex model that the dimerization site of ErbB-2 is in the open as an for the heterodimerization with ErbB-2. an of this be a mechanism to the formation of ErbB-2/ErbB-3 complexes and to biologically inactive ErbB-3 homodimers. In this be the natural ligand ErbB-2 is in ErbB-3, the low affinity be that ErbB-3 is in ErbB-2 R. M. S. Ratzkin B.J. Yarden Y. J. Biol. Chem. 1996; Scholar, Akita R.W. Sliwkowski M.X. Scholar). in the cell a of cellular We Y. Yarden and D. of for the of the and the proteins. The by
34
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Hideo Ogiso, Ryuichiro Ishitani, Osamu Nureki et al. · Cell · 2002 · 1.2K citations · Full text